Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.85
+0.22 (3.91%)
At close: Feb 18, 2026, 4:00 PM EST
5.73
-0.12 (-2.02%)
After-hours: Feb 18, 2026, 5:33 PM EST
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $321.16 million as of February 18, 2026. Its market cap has increased by 5.75% in one year.
Market Cap
321.16M
Enterprise Value
241.40M
1-Year Change
5.75%
Ranking
Category
Stock Price
$5.85
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $321.16M, an increase of 44.41%. That is a compound annual growth rate of 8.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 321.16M | 3.54% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 336.73M |
| Foghorn Therapeutics | 324.54M |
| Immuneering | 318.33M |
| Aldeyra Therapeutics | 317.66M |
| Century Therapeutics | 314.38M |
| Cybin | 304.72M |
| X4 Pharmaceuticals | 298.16M |
| XOMA Royalty | 297.32M |